This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Tonron International Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thomas Kleen: Innovator in Cancer Therapy
Introduction
Thomas Kleen is a notable inventor based in Uxbridge, GB. He has made significant contributions to the field of cancer therapy through his innovative research and development. His work focuses on utilizing mycobacterium as an immunomodulator to enhance cancer treatment options.
Latest Patents
Thomas Kleen holds a patent for his invention titled "Mycobacterium for use in cancer therapy." This invention provides an immunomodulator for the treatment, reduction, inhibition, or control of cancer in subjects classified with varying performance statuses according to the ECOG Scale. The patent also outlines the use of additional anticancer treatments and specifies protocols and dosage regimens for effective application.
Career Highlights
Throughout his career, Thomas has demonstrated a commitment to advancing cancer treatment methodologies. His innovative approach has the potential to improve the quality of life for patients who may not be able to tolerate traditional chemotherapy regimens.
Collaborations
Thomas Kleen collaborates with Jakob Kampinga, contributing to the development of new therapeutic strategies in cancer treatment.
Conclusion
Thomas Kleen's work exemplifies the impact of innovation in the medical field, particularly in cancer therapy. His contributions are paving the way for more effective treatment options for patients facing challenging health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile